PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsWhy the drugs don't work: gene fault explains multiple sclerosis treatment failure

BioNews

Why the drugs don't work: gene fault explains multiple sclerosis treatment failure

Published 23 November 2012 posted in News and appears in BioNews 666

Author

Holly Rogers

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A genetic variation could explain why a previously promising class of drugs do not work as multiple sclerosis treatments despite being used successfully in other autoimmune diseases...

A genetic variation could explain why a previously
promising class of drugs does not work as treatment for multiple sclerosis (MS),
despite being used successfully in other autoimmune diseases.

The drugs, known as anti-TNFs - they
inhibit the action of a chemical in the body called tumour necrosis factor
(TNF) - are an established therapy for patients with inflammatory bowel disease
and rheumatoid arthritis.

But a study carried out ten years ago showed
that anti-TNFs can in fact worsen symptoms of MS. At the time, the reasons
for this were unknown. Some experts suggested the drugs could even trigger the
disease in those predisposed to the condition.

In the
current study, the team from Oxford University investigated a genetic variant
found in a gene already associated with a risk of developing MS.

The gene encodes TNF receptor 1 protein. Normally, this protein sits within a cell's membrane,
where it senses TNF circulating outside the cell. Its activation starts a
cascade that can lead to inflammation and cell death.

However, researchers found that the variant
produces a shortened version of the protein, which is released outside of the
cell, instead of anchoring to its membrane. It then 'mops up' TNF molecules,
preventing them from signalling to cells and effectively performing the same
process as anti-TNF drugs.

'Whilst [this] gene variant is linked to a modest
risk of developing MS, the drug that mimics the effect of the variant has a
considerably greater impact', said Professor
Lars Fugger of the Nuffield Department of Clinical Neurosciences, who led the
study. 'The effects of genetic variants influencing
disease risk or resistance can be amplified by drugs. This has often been
completely overlooked, but will be critical for using genetic findings in a
medical context'.

The variant was
discovered using a genome-wide association study
(GWAS), published in Nature. GWAS
collect data from thousands of people with a particular disease, and identify
genetic variations that are more prevalent in those with the condition. Most studies of this kind discover dozens of significant
variations, each increasing the chances of developing the condition by a small
percentage.

Analysing the entire human genome has raised
the hope that genetic abnormalities can be identified and used to refine or
identify treatments for patients with certain disorders.

Professor Fugger said that the study 'shows that
this is possible. It's one of the first such examples, certainly in autoimmune
disease'.

Nick Rijke,
director of policy and research at the MS Society, told BBC News that the study
'could help ensure that people with MS are offered the drug treatments that are
most likely to work for them'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 May 2017 • 1 minute read

Gene associated with treatment-resistant ovarian cancers identified

by Chris Baldacci

Scientists have discovered a gene called FGF1 which is highly active in aggressive and advanced ovarian cancers...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 August 2015 • 2 minutes read

Genetic findings confirm vitamin D—MS link

by Lubna Ahmed

A recent study by researchers in Canada has found that people who are genetically susceptible to low vitamin-D levels are at a higher risk of multiple sclerosis...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
7 October 2013 • 2 minutes read

Global study finds 48 new multiple sclerosis risk genes

by Julianna Photopoulos

A group of international researchers has identified 48 new genetic variants that influence the risk of developing multiple sclerosis. This brings the number of genetic 'risk factors' linked to the disease to 110...

PET BioNews
News
20 March 2013 • 1 minute read

DNA damage during chemotherapy can trigger treatment resistance

by Dr Caroline Hirst

Chemotherapy can produce a rogue response that eventually leads to tumours becoming resistant to treatment, scientists have found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 March 2013 • 2 minutes read

Scientists unpick actions of faulty gene behind red meat bowel cancer risk

by Cait McDonagh

A faulty gene linked to bowel cancer interacts with dietary iron to significantly increase the risk of developing the disease, research on mice suggests...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
23 January 2013 • 2 minutes read

Multiple sclerosis and vitamin D linked by rare genetic variant

by Owen Clark

A rare genetic variant causing lower levels of vitamin D has been linked to multiple sclerosis (MS), according to scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 November 2012 • 2 minutes read

Study finds new genetic variants associated with MS

by Rebecca Hill

Researchers have identified 29 new genetic variants with a link to multiple sclerosis (MS). This brings the total number of genetic changes associated with the disease, which affects around 2.5 million people worldwide, to nearly 50...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 November 2012 • 1 minute read

MS the result of genetics and environment, study suggests

by Mehmet Fidanboylu

Researchers have found a link between genetics and the environment that may help to explain the development of multiple sclerosis (MS). The study, published in Nature Communications, identified how vitamin D obtained through diet or sunlight, interacts with certain genes...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
13 December 2010 • 1 minute read

Study examines how the body repairs myelin, which may help MS patients

by Dr Christopher Chatterton

Preliminary findings from a new research study have helped give scientists a new insight into how the body naturally repairs myelin, the substance that insulates nerve cells in the brain...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genome researchers track and stop spread of killer bug

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856